Optimize NHS Primary Care Across Cardio-Reno-Metabolic pathways

Metadvice AI | Smart AI to prevent heart attacks and strokes

Smart AI to prevent heart attacks and strokes

Metadvice empowers clinicians with real-time, evidence-based treatment recommendations for patients with cardiometabolic conditions. Our neural network analyses patient data instantly, ensuring adherence to NICE guidelines whilst optimising care for complex comorbidities. Our tool is fully compliant and integrated with EMIS Web and TPP SystmOne.

Arrange a Demo Find Out More
CE-Marked Medical Device Class IIa (EU-MDR) ISO Certified Cyber Essentials Plus

Platform Capabilities

Population Analytics

Identify high-risk patients and prioritise by clinical need

Clinical Decision Support

Real-time treatment recommendations aligned to NICE guidance

Predictive Heart Failure

Early detection at 3-year horizon with >85% accuracy

Clinical Focus: HTN, T2DM, CVD Prevention, Heart Failure, CKD, AF

Proven Clinical Impact

Real-world evidence from practices serving 50,000+ patients demonstrates statistically significant improvements in guideline adherence and therapy success.

Improvement in Adherence to NICE Guidance

10-15%

Hypercholesterolemia

where Metadvice consulted within 30 days of therapy change (p-value < 0.035)

Improvement in Adherence to NICE Guidance

66-100%

Type 2 Diabetes

where Metadvice consulted within 30 days of therapy change (p-value < 0.003)

Improvement in Therapy Success

15-30%

Hypertension

where Metadvice consulted within 60 days of therapy change (p-value < 0.04)

Client Testimonials

Hear from primary care professionals using Metadvice to transform patient outcomes

"We're able to identify particular cohorts at risk in secondary prevention, those that may be suboptimally treated or not treated at all, and prioritise who we're contacting.

It makes it easier to manage the workload, and means patients can see the right person to help them.

Really helped the team, giving confidence that they were looking at the latest NICE guidance, and allowing those professionals to take a wider view - be much more proactive, spend more time with the patient, and understand what's most important to them."

Dr Shona Schofield

GP Partner & PCN Clinical Director

Lancing PCN, Ball Tree Surgery

"It's extremely quick and useful. I'm using it for every patient to help with my next treatment decision."

Sarah Cosgrove

Lead Pharmacist, Ball Tree Surgery

"Metadvice have consistently provided close support during implementation of their software. Metadvice are committed to developing close working relationships with clinicians to ensure that the software achieves their needs; identifying patients at risk of harm, and providing easily accessible pathways to optimise care for each individual.

Metadvice is a tool that can reach patients previously invisible to us, allowing us to proactively manage their risk factors and allocate our clinical resources in the best way possible."

James Read

GP Partner | Director of Prescribing and Medicines Optimisation

Haxby Group; York, Hull and Scarborough

Intelligent, Evidence-Based Clinical Support

Metadvice AI has been trained on evidence-based best practice guidelines, delivering personalized risk evaluations and treatment plans at the point of care.

How Metadvice Works

Our Neural Network AI analyses patient data in real-time, considering comorbidities, polypharmacy, and individual risk factors to recommend optimal medication sequences tailored to each patient.

  • Fully integrated with EMIS Web and TPP SystmOne - no separate login required
  • Personalised risk evaluations with relevant NICE guidance (including QRISK3, CHA₂DS₂-VASc)
  • Recommends dosing adjustments for improved response
  • Predictive analytics for treatment outcomes
  • Identifies optimal medication combinations and sequences
  • Predicts probability of allergy or intolerance

Key Benefits

Save Time

All relevant patient information and calculations on a single screen - no more scrolling through records

Build Confidence

Evidence-based recommendations aligned to latest NICE guidance for complex patients

Improve Outcomes

Proven to increase guideline adherence and therapy success rates

Predictive AI: Early Heart Failure Detection

Our neural network predicts heart failure risk at a 3-year horizon with >85% accuracy, enabling early intervention and improved patient outcomes.

21 Biometrics Analysed Daily

• Age, BMI, Systolic Blood Pressure
• eGFR, Glycated Hemoglobin (A1c)
• Liver enzymes (ALAT, ASAT)
• BNP, CRP, Creatinine
• Heart Rate, LDL Cholesterol
• Blood Sodium, RDW, MCHC
• Albumin levels, Blood Urea, WBC
• Gender and additional biomarkers
All biometrics analysed instantly using up-to-date patient data

How It Works

Metadvice extracts and analyses all relevant biometrics from patient records, identifying those at high risk of developing heart failure within three years.

Neural Network Matching: Matches individual patients to similar biometric fingerprints from analysis of 100,000s of patients
Early Detection: Identifies patients at risk before symptoms appear
Explainable AI: Shows relative contribution of each biometric to risk
Actionable Insights: Recommends co-morbidity management plans
Focus on 40-70 Year Olds: Target population for maximum preventative impact